Literature DB >> 31619395

Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Larry Reitzer1, Philippe Zimmern2.   

Abstract

Uropathogenic Escherichia coli (UPEC) strains cause a majority of urinary tract infections (UTIs). Since UPEC strains can become antibiotic resistant, adjunct or alternate therapies are urgently needed. UPEC strains grow extremely rapidly in patients with UTIs. Thus, this review focuses on the relation between urine composition and UPEC growth and metabolism. Compilation of urinary components from two major data sources suggests the presence of sufficient amino acids and carbohydrates as energy sources and abundant phosphorus, sulfur, and nitrogen sources. In a mouse UTI model, mutants lacking enzymes of the tricarboxylic acid cycle, gluconeogenesis, and the nonoxidative branch of the pentose cycle are less competitive than the corresponding parental strains, which is consistent with amino acids as major energy sources. Other evidence suggests that carbohydrates are required energy sources. UPEC strains in urine ex vivo and in vivo express transporters for peptides, amino acids, carbohydrates, and iron and genes associated with nitrogen limitation, amino acid synthesis, nucleotide synthesis, and nucleotide salvage. Mouse models confirm the requirement for many, but not all, of these genes. Laboratory evolution studies suggest that rapid nutrient uptake without metabolic rewiring is sufficient to account for rapid growth. Proteins and pathways required for rapid growth should be considered potential targets for alternate or adjunct therapies.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Escherichia coli; carbon metabolism; iron metabolism; nitrogen metabolism; nucleotide metabolism; urinary tract infection

Mesh:

Substances:

Year:  2019        PMID: 31619395      PMCID: PMC6927312          DOI: 10.1128/CMR.00101-19

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  118 in total

1.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

2.  Metabolic phenotyping of the Yersinia high-pathogenicity island that regulates central carbon metabolism.

Authors:  Leyu Yan; Wenna Nie; Haitao Lv
Journal:  Analyst       Date:  2015-04-14       Impact factor: 4.616

3.  Enzymatic assay of D-mannose from urine.

Authors:  Iti Mehta; Philippe Zimmern; Larry Reitzer
Journal:  Bioanalysis       Date:  2018-11-06       Impact factor: 2.681

4.  A central metabolic circuit controlled by QseC in pathogenic Escherichia coli.

Authors:  Maria Hadjifrangiskou; Maria Kostakioti; Swaine L Chen; Jeffrey P Henderson; Sarah E Greene; Scott J Hultgren
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

5.  Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial.

Authors:  Thomas M Hooton; Mariacristina Vecchio; Alison Iroz; Ivan Tack; Quentin Dornic; Isabelle Seksek; Yair Lotan
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

6.  Genomic islands of uropathogenic Escherichia coli contribute to virulence.

Authors:  Amanda L Lloyd; Tiffany A Henderson; Patrick D Vigil; Harry L T Mobley
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

7.  Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073.

Authors:  Andrew T Anfora; Brian J Haugen; Paula Roesch; Peter Redford; Rodney A Welch
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

8.  1H NMR spectroscopy-based metabolomics analysis for the diagnosis of symptomatic E. coli-associated urinary tract infection (UTI).

Authors:  Milena Lussu; Tania Camboni; Cristina Piras; Corrado Serra; Francesco Del Carratore; Julian Griffin; Luigi Atzori; Aldo Manzin
Journal:  BMC Microbiol       Date:  2017-09-21       Impact factor: 3.605

9.  Deciphering Fur transcriptional regulatory network highlights its complex role beyond iron metabolism in Escherichia coli.

Authors:  Sang Woo Seo; Donghyuk Kim; Haythem Latif; Edward J O'Brien; Richard Szubin; Bernhard O Palsson
Journal:  Nat Commun       Date:  2014-09-15       Impact factor: 14.919

10.  In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles.

Authors:  Piotr Bielecki; Uthayakumar Muthukumarasamy; Denitsa Eckweiler; Agata Bielecka; Sarah Pohl; Ansgar Schanz; Ute Niemeyer; Tonio Oumeraci; Nils von Neuhoff; Jean-Marc Ghigo; Susanne Häussler
Journal:  MBio       Date:  2014-08-05       Impact factor: 7.867

View more
  15 in total

1.  Preferential catabolism of l- vs d-serine by Proteus mirabilis contributes to pathogenesis and catheter-associated urinary tract infection.

Authors:  Aimee L Brauer; Brian S Learman; Steven M Taddei; Namrata Deka; Benjamin C Hunt; Chelsie E Armbruster
Journal:  Mol Microbiol       Date:  2022-08-15       Impact factor: 3.979

2.  Rapid Fluorescence Sensor Guided Detection of Urinary Tract Bacterial Infections.

Authors:  Lei Zhang; Bing Wang; Guo Yin; Jue Wang; Ming He; Yuqi Yang; Tiejie Wang; Ting Tang; Xie-An Yu; Jiangwei Tian
Journal:  Int J Nanomedicine       Date:  2022-08-26

3.  Whole-genome-sequence-based characterization of an NDM-5-producing uropathogenic Escherichia coli EC1390.

Authors:  Tran Thi Dieu Thuy; Hsu-Feng Lu; Pei-Yun Kuo; Wei-Hung Lin; Tzu-Ping Lin; Yi-Tzu Lee; Tran Thi Thuy Duong; Ming-Cheng Wang; Yi-Hong Lee; Li-Li Wen; Yu-Chen Chen; Cheng-Yen Kao
Journal:  BMC Microbiol       Date:  2022-06-06       Impact factor: 4.465

4.  Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.

Authors:  Steven P Djordjevic; Monika Dolejska; Kristina Nesporova; Ethan R Wyrsch; Adam Valcek; Ibrahim Bitar; Khin Chaw; Patrick Harris; Jaroslav Hrabak; Ivan Literak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study.

Authors:  Michelle Kalu; Karen Tan; Marquerita Algorri; Peter Jorth; Annie Wong-Beringer
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

6.  A strategy design based on antibiotic‑resistance and plasmid replicons genes of clinical Escherichia coli strains.

Authors:  Junyan Liu; Xin Lin; Thanapop Soteyome; Yanrui Ye; Dingqiang Chen; Ling Yang; Zhenbo Xu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 7.  Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection.

Authors:  Michael L Neugent; Neha V Hulyalkar; Vivian H Nguyen; Philippe E Zimmern; Nicole J De Nisco
Journal:  mBio       Date:  2020-04-28       Impact factor: 7.867

8.  Diversity in the swimming motility and flagellar regulon structure of uropathogenic Morganella morganii strains.

Authors:  Leyla Minnullina; Zarina Kostennikova; Vladimir Evtugin; Yaw Akosah; Margarita Sharipova; Ayslu Mardanova
Journal:  Int Microbiol       Date:  2021-08-07       Impact factor: 2.479

Review 9.  Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems.

Authors:  Benjamin O Murray; Carlos Flores; Corin Williams; Deborah A Flusberg; Elizabeth E Marr; Karolina M Kwiatkowska; Joseph L Charest; Brett C Isenberg; Jennifer L Rohn
Journal:  Front Cell Infect Microbiol       Date:  2021-05-26       Impact factor: 5.293

10.  Tailoring a Global Iron Regulon to a Uropathogen.

Authors:  Rajdeep Banerjee; Erin Weisenhorn; Kevin J Schwartz; Kevin S Myers; Jeremy D Glasner; Nicole T Perna; Joshua J Coon; Rodney A Welch; Patricia J Kiley
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.